GlobeNewswire News Room·2025-05-26 12:21Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Elevance Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to allegations that Elevance Health made false or misleading statements regarding the impact of Medicaid redetermination on its financial guidance and cost trends [4]. - Investors who purchased Elevance common stock between April 18, 2024, and October 16, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][4]. - The deadline to move the Court to serve as lead plaintiff is July 11, 2025, and a lead plaintiff acts on behalf of other class members [2]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant amounts for investors [3]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company at the time and ranking highly in securities class action settlements since 2013 [3]. Group 3: Case Specifics - The lawsuit claims that Elevance Health misrepresented the adequacy of its premium rates and the monitoring of cost trends related to Medicaid, leading to significant investor damages when the true situation was revealed [4].